Oligodendroglioma IDH-mutant and 1p/19q-codeleted
3 clinical trials · Condition
◉ Watch Oligodendroglioma IDH-mutant and 1p/19q-codeleted
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy Study of Safusidenib in Participants With Grade 2 IDH1-Mutant Glioma (NCT07712757) | Nuvation Bio Inc. | 2027-03-01 |
| Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy (NCT06625047) | Mayo Clinic | 2024-10-07 |
| SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance) (NCT05303519) | Nuvation Bio Inc. | 2023-06-05 |
Track Oligodendroglioma IDH-mutant and 1p/19q-codeleted automatically
Every clearance here is in the API, with alerts when new ones post.